招銀國際:比亞迪(01211.HK)成為中國11月最暢銷汽車品牌
招銀國際數據顯示,在11月的首4個星期比亞迪(01211.HK)成為中國最暢銷汽車品牌,表現優於福士汽車,而Tesla(TSLA.US)在中國的銷售亦按年增長近一倍。
11月1日至11月27日期間,比亞迪汽車零售量為15.2863萬輛,日均銷量按年增長近83%。而福士汽車及豐田汽車則分別下降0.3%及0.5%,至14.3602萬及11.5272萬輛。不過若計及奧迪品牌的3.6847萬輛,福士汽車銷量仍然超過比亞迪。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.